SOURCE: ALR Technologies Inc.

March 12, 2012 09:43 ET

ALR Technologies to Host Investor Meeting Discussing Diabetes Management System

RICHMOND, VA--(Marketwire - Mar 12, 2012) - ALR Technologies Inc. (OTCBB: ALRT) (the "Company"), a healthcare technology company, is pleased to announce that it will be hosting an investor meeting after the market closes on Monday, March 19, 2012 at 4:30 PM EDT. The meeting will be conducted in a webinar format, including an investor presentation by Sidney S. Chan, Chairman and Chief Executive Officer at ALR Technologies, providing details on corporate developments and product launch of the Company's Health-e-Connect (HeC) system.

HeC has received 510(k) clearance from the U.S. Food and Drug Administration for remote monitoring of patients in support of effective diabetes management programs. Senior executives at ALR Technologies have been making substantial headway in meeting with business leaders and policymakers nationwide to discuss the Company's innovative technology platform and how it can both improve outcomes for diabetes patients and curb healthcare spending while creating jobs in the United States.

"We have been making great strides in our strategy to bring HeC to market as a solution in chronic disease management," commented Mr. Chan. "I look forward to updating and visiting with our shareholders in the upcoming meeting."

Registration is required to attend the investor meeting and space is limited. To access the webinar, interested parties can reserve their seat by visiting:

For those unable to participate during the live meeting, an archived replay of the event will be available for a period of time in the investor section of the Company's website ( approximately two hours after the webinar ends on March 19th.

About ALR Technologies Inc.
ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web-based patient management platform for medical professionals to improve compliance and management of care plans of patients in their homes. HeC is currently programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the Company's quarterly filings with the Securities Exchange Commission.

Contact Information

  • Public Relations:
    ALR Technologies Inc.
    804-554-3500 Ext. 704